Results 31 to 40 of about 13,610 (191)
Clinical Case Reports, 2021 A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events.
Akiko Hashimoto +3 more
doaj +1 more source
Arsenic trioxide and neuroblastoma cytotoxicity. [PDF]
, 2007 The majority of aggressive forms of the childhood tumor neuroblastoma can with current treatment protocols not be cured and possess a major challenge in pediatric oncology.
Påhlman, Sven +4 more
core +1 more source
Di-san junyi daxue xuebao, 2022 Objective To investigate the molecular mechanism of oprozomib synergistically acting with arsenic trioxide in inhibiting the proliferation of acute promyeloid leukemia cells.
DING Xin +4 more
doaj +1 more source
Journal of Advanced Veterinary and Animal Research, 2022 Objectives: The purpose of this research was to look into the impacts after the implication of feeding broiler chickens with spirulina in arsenic-incited toxicities.
Md. Mowdudul Hasan Talha +5 more
doaj +1 more source
Advanced Science, 2019 The latent viral reservoir is the source of viral rebound after interruption of antiretroviral therapy (ART) and is the major obstacle in eradicating the latent human immunodeficiency virus‐1 (HIV‐1).
Qing Yang +16 more
doaj +1 more source
Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia. [PDF]
PLoS ONE, 2016 AIM:All-trans retinoic acid combined to anthracycline-based chemotherapy is the standard regimen of acute promyelocytic leukemia. The advent of arsenic trioxide has contributed to improve the anti-leukemic efficacy in acute promyelocytic leukemia.
Ye Zhang +4 more
doaj +1 more source
, 2009 Parenteral administration of arsenic trioxide has recently been recognized as an effective antineoplastic therapy, especially for the treatment of acute promyelocytic leukemia . Its efficacy and toxicity are concentration-dependent and are related to the
林君榮;吳美環;薛玉梅;辛肇敏;鄭安理 +1 more
core +1 more source
Method For Inhibiting Cancer Using Arsenic Trioxide [PDF]
, 2008 The Invention Provides A Method For Treating Cancers That Are Dependent On Cyclin D1 For Proliferation, Survival, Metastasis And Differentiation, Involving Administering A Composition Containing An Effective Amount Of Arsenic Trioxide To An Affected ...
core +4 more sources
Arsenic trioxide as a novel anti-glioma drug: a review
Cellular & Molecular Biology Letters, 2020 Arsenic trioxide has shown a strong anti-tumor effect with little toxicity when used in the treatment of acute promyelocytic leukemia (APL). An effect on glioma has also been shown.
Yi Fang, Zhen Zhang
doaj +1 more source
口腔疾病防治, 2023 Objective To investigate the etiology, clinical manifestations, treatment and prevention of jaw necrosis caused by arsenic trioxide to provide a reference for clinical diagnosis and treatment.
WANG Liping +2 more
doaj +1 more source